Home / Innere Medizin / Onkologie / ASCO 2018 – Daily Quizzes

ASCO 2018 – Daily Quizzes

Daily Quiz 1

Which statement on biomarkers of PD-(L)-1 expression is correct?

(Select the correct answer)

Submit

Daily Quiz 2

Which statement about pseudoprogression under immunotherapy is correct?

(Select the correct answer)

Submit

Daily Quiz 3

Immune-related endocrine adverse events can last even after end of treatment. When can the first onset of hypophysitis under CTLA-4-inhibitor therapy typically be expected?

(Select the correct answer)

Submit

Daily Quiz 4

Which of these biomarker statements are correct?

(Select 3 answers)

Submit

Daily Quiz 5

Which of these bacteria species as part of the gut microbioma were associated with response to immune checkpoint inhibition?

(Select 3 answers)

Submit

Daily Quiz 6

Which endocrinopathies are most commonly observed related to immune checkpoint inhibitor therapy?

(Select 3 answers)

Submit

Daily Quiz 7

What treatment is the standard of care in advanced BRAFV600-mutant melanoma?

(Select the correct answer)

Submit

Daily Quiz 8

Which of these statements are correct?

(Select 3 answers)

Submit

Hint: You can find the answers in our videos and news articles

Daily Quiz 9

Which of these statements on the Circulating Cell-Free Genome Atlas (CCGA) study are correct?

(Select 3 answers)

Submit

Daily Quiz 10

Which of these statements on urothelial carcinoma studies are correct?

(Select 3 answers)

Submit

Hint: The answers can be found in Univ.-Prof. Dr. Shahrokh F. Shariat's Breakfast Brief.

 

LOGIN

Login

Passwort vergessen?